A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
Clinical trial NCT04271475 · TERMINATED
Trial details
- NCT number
- NCT04271475
- Sponsor
- Actelion
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-07
- Primary completion
- 2023-12-21
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.